|
2.5 ETIOLOGIE - GÉNOME
|
|
|
|
3.1.1 PRÉVENTION - TABAC - E-CIGS
|
|
|
|
5.1 TRAITEMENTS - PRÉ-CLINIQUE
|
|
|
|
5.12 IMMUNOTHÉRAPIES
|
|
|
|
5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE
|
|
|
|
5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES
|
|
|
Promising new treatment for recurrent pediatric brain cancer [Baylor]
|
|
|
|
|
|
A multi-institutional, international team led by researchers at Baylor College of Medicine, Texas Children’s Hospital and the Hospital for Sick Children (SickKids) has developed a novel approach that delivers appropriately-targeted chimeric antigen receptor (CAR) T cell therapy directly into the cerebrospinal fluid that surrounds the tumor.
|
|
|
|
|
|
|
5.12.5 IMMUNOTHÉRAPIES - PHARMA
|
|
|
|
|
|
|
5.2 PHARMA
|
|
|
|
5.2.6 PHARMA - BIOTECH
|
|
|
|
5.9 AACR
|
|
|
|
|
American Association for Cancer Research (AACR) 2020 Virtual Meeting Preview [OBR]
|
|
|
|
|
|
AACR President-Elect Antoni Ribas, MD, PhD, focused on clinical trials to be presented at eight Plenary Sessions during the virtual meeting, and added that there would be a wide array of other presentations featured over the two-days, including mini-symposia, posters, award-winning lectures, and a special session on coronavirus and cancer.
|
|
|
|
|
|
|
5.9.1 AACR - SEIN
|
|
|
|
|
5.9.10 AACR - COLORECTAL
|
|
|
|
5.9.12 AACR - BIOPSIES LIQUIDES
|
|
|
|
5.9.2 AACR - HÉMATO
|
|
|
|
5.9.3 AACR - MÉLANOME
|
|
|
|
|
5.9.4 AACR - POUMON
|
|
|
|
5.9.5 AACR - CAR-T, THÉRAPIES CELLULAIRES
|
|
|
|
|
|
5.9.7 AACR - DIVERS
|
|
|
|
5.9.9 AACR - IMMUNOTHÉRAPIES
|
|
|
AACR: Compugen's checkpoint inhibitor keeps cancer in check [Fierce Biotech]
|
|
|
|
|
|
Compugen’s anti-PVRIG antibody showed early promise in a small phase 1 study, curbing tumor growth in more than two-thirds of patients with various solid tumors who had exhausted all other treatment options. The treatment did similarly in tandem with Bristol Myers Squibb’s PD-1 blocker Opdivo, stopping tumor growth in three-quarters of patients.
|
|
|
|
|
|
|
6.15 LUTTE CONTRE LES CANCERS - COVID-19
|
|
|